A meta-analysis of 11 case-control studies with 2,808 glioma cases and 3,114 control subjects identified that the XRCC1 Arg399Gln polymorphism may contribute to the susceptibility to gliomas in Asian individuals (30). Here, XRCC1 is linked to central nervous system cancer.